Matches in Wikidata for { <http://www.wikidata.org/entity/Q64150276> ?p ?o ?g. }
Showing items 1 to 36 of
36
with 100 items per page.
- Q64150276 description "clinical trial" @default.
- Q64150276 description "ensayu clínicu" @default.
- Q64150276 description "klinisch onderzoek" @default.
- Q64150276 description "клінічне випробування" @default.
- Q64150276 name "Lirilumab With Rituximab for Relapsed, Refractory or High-risk Untreated Chronic Lymphocytic Leukemia (CLL) Patients" @default.
- Q64150276 type Item @default.
- Q64150276 label "Lirilumab With Rituximab for Relapsed, Refractory or High-risk Untreated Chronic Lymphocytic Leukemia (CLL) Patients" @default.
- Q64150276 prefLabel "Lirilumab With Rituximab for Relapsed, Refractory or High-risk Untreated Chronic Lymphocytic Leukemia (CLL) Patients" @default.
- Q64150276 P1050 Q64150276-EA4F3A3C-72B2-4707-A968-01754E5C236E @default.
- Q64150276 P1132 Q64150276-F44CC021-82F0-49E3-96E2-3619FACB17A7 @default.
- Q64150276 P1476 Q64150276-DE2E5E4A-8481-4789-B717-E6EA4DC338C9 @default.
- Q64150276 P17 Q64150276-EFB16324-6ED0-498B-990C-586656AE69B9 @default.
- Q64150276 P2899 Q64150276-03A80609-B455-4285-80E5-4C1DA6BE0057 @default.
- Q64150276 P3098 Q64150276-60E987F8-C98A-49DD-9469-AC3B33E1FF4C @default.
- Q64150276 P31 Q64150276-673064FB-1036-4E03-B5A5-C8D82DD9EBFA @default.
- Q64150276 P4844 Q64150276-7A1BD937-A6E3-4388-AC04-271307A6BD41 @default.
- Q64150276 P580 Q64150276-86AF4C88-1004-47B7-81BD-D36EEF497E86 @default.
- Q64150276 P582 Q64150276-4EF1E912-CED2-48CA-B0A3-B876C1947B7D @default.
- Q64150276 P6099 Q64150276-8B139525-2266-451C-8E7B-7AF2ECE2B770 @default.
- Q64150276 P6153 Q64150276-1C91669A-9A5C-4026-A4F5-87A16DCFA423 @default.
- Q64150276 P767 Q64150276-D993A10B-F753-4BD7-9A60-33B5769350DC @default.
- Q64150276 P8363 Q64150276-39C109EF-9174-4B6C-8865-FD5704DB89DB @default.
- Q64150276 P1050 Q29496 @default.
- Q64150276 P1132 "+8" @default.
- Q64150276 P1476 "Lirilumab (Anti-KIR mAb) Combined With Rituximab for Relapsed, Refractory or High-risk Untreated Patients With Chronic Lymphocytic Leukemia (CLL)" @default.
- Q64150276 P17 Q30 @default.
- Q64150276 P2899 "+18" @default.
- Q64150276 P3098 "NCT02481297" @default.
- Q64150276 P31 Q30612 @default.
- Q64150276 P4844 Q412323 @default.
- Q64150276 P580 "2015-06-23T00:00:00Z" @default.
- Q64150276 P582 "2021-06-01T00:00:00Z" @default.
- Q64150276 P6099 Q42824440 @default.
- Q64150276 P6153 Q1525831 @default.
- Q64150276 P767 Q266423 @default.
- Q64150276 P8363 Q78089383 @default.